Incretin therapy for obesity: efficacy, safety, and compliance
Obesity remains one of the major comorbidities in the today’s world’s population that is of pandemic nature. Unfortunately, the rapid annual increase in the prevalence of obesity as a multisystemic disorder affecting almost all organs and systems is acknowledged. It has been proven that obesity incr...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
LLC "MEDIAFORMAT"
2026-02-01
|
| Schriftenreihe: | Клинический разбор в общей медицине |
| Schlagworte: | |
| Online-Zugang: | https://klin-razbor.ru/en/archive/2026/vol-7-2-2026/incretin-therapy-for-obesity-efficacy-safety-and-compliance-_7639/?element |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
